फेविपिराविर (Hindi Wikipedia)

Analysis of information sources in references of the Wikipedia article "फेविपिराविर" in Hindi language version.

refsWebsite

Global rank Hindi rank

46nih.gov

4^th place

7^th place

27doi.org

2^nd place

5^th place

4worldcat.org

5^th place

8^th place

3harvard.edu

18^th place

56^th place

2medum.ru

low place

2reuters.com

49^th place

168^th place

1business-standard.com

350^th place

52^nd place

1fiercepharma.com

low place

1bloomberg.com

99^th place

164^th place

1biospace.com

low place

1diamond.jp

2,938^th place

low place

1telex.hu

6,756^th place

low place

1dnaindia.com

250^th place

50^th place

1com.bd

low place

1thewire.in

1,507^th place

225^th place

1principletrial.org

low place

1allafrica.com

1,467^th place

8,495^th place

1croiconference.org

low place

1nytimes.com

7^th place

49^th place

1sciencemag.org

857^th place

733^rd place

allafrica.com

"Guinea: Clinical Trial for Potential Ebola Treatment Started in MSF Clinic in Guinea". AllAfrica – All the Time. अभिगमन तिथि 28 December 2014.

biospace.com

"MediVector Completes Patient Enrollment In Two Phase 3 Studies Of Favipiravir For Influenza". BioSpace. अभिगमन तिथि 5 May 2020.

bloomberg.com

Koons, Cynthia (7 August 2014). "Ebola Drug From Japan May Emerge Among Key Candidates". Bloomberg.com.

business-standard.com

India, Press Trust of (20 June 2020). "Glenmark launches Covid-19 drug FabiFlu, priced at Rs 103 per tablet". Business Standard India.

com.bd

medex.com.bd

"Favipira - Tablet - 200 mg - Beacon Pharmaceuticals Ltd. - Indications, Pharmacology, Dosage, Side Effects & other Generic Info". Medex. अभिगमन तिथि 22 July 2020.

croiconference.org

"Favipiravir in Patients with Ebola Virus Disease: Early Results of the JIKI trial in Guinea". CROIconference.org. अभिगमन तिथि 2016-03-17.

diamond.jp

条件付き承認で普及に足かせ富山化学インフル薬の"無念" (जापानी में). अभिगमन तिथि 25 February 2014.

dnaindia.com

"'FabiFlu is the most economical COVID-19 treatment option': Glenmark's reply to Centre on alleged 'overpricing'". DNA India. 21 July 2020. अभिगमन तिथि 22 July 2020.

doi.org

Du YX, Chen XP (April 2020). "Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection". Clinical Pharmacology and Therapeutics. 108 (2): 242–247. PMID 32246834. डीओआइ:10.1002/cpt.1844.
Furuta, Yousuke; Takahashi, Kazumi; Shiraki, Kimiyasu; Sakamoto, Kenichi; Smee, Donald F.; Barnard, Dale L.; Gowen, Brian B.; Julander, Justin G.; Morrey, John D. (2009). "T-705 (Favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections". Antiviral Research. 82 (3): 95–102. PMID 19428599. डीओआइ:10.1016/j.antiviral.2009.02.198. पी॰एम॰सी॰ 7127082 |pmc= के मान की जाँच करें (मदद).
Shiraki K, Daikoku T (February 2020). "Favipiravir, an anti-influenza drug against life-threatening RNA virus infections". Pharmacology & Therapeutics. 209: 107512. PMID 32097670. डीओआइ:10.1016/j.pharmthera.2020.107512. पी॰एम॰सी॰ 7102570 |pmc= के मान की जाँच करें (मदद). सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "Shi2020" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
Pilkington, Victoria; Pepperrell, Toby; Hill, Andrew (2020). "A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?". Journal of Virus Eradication. 6 (2): 45–51. PMID 32405421. आइ॰एस॰एस॰एन॰ 2055-6640. डीओआइ:10.1016/S2055-6640(20)30016-9. पी॰एम॰सी॰ 7331506 |pmc= के मान की जाँच करें (मदद).
Jin Z, Smith LK, Rajwanshi VK, Kim B, Deval J (2013). "The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase". PLOS ONE. 8 (7): e68347. PMID 23874596. डीओआइ:10.1371/journal.pone.0068347. पी॰एम॰सी॰ 3707847. बिबकोड:2013PLoSO...868347J. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "bp" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
Guedj J, Piorkowski G, Jacquot F, Madelain V, Nguyen TH, Rodallec A, एवं अन्य (March 2018). "Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques". PLOS Medicine. 15 (3): e1002535. PMID 29584730. डीओआइ:10.1371/journal.pmed.1002535. पी॰एम॰सी॰ 5870946.
Smee DF, Hurst BL, Egawa H, Takahashi K, Kadota T, Furuta Y (October 2009). "Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells". The Journal of Antimicrobial Chemotherapy. 64 (4): 741–6. PMID 19643775. डीओआइ:10.1093/jac/dkp274. पी॰एम॰सी॰ 2740635.
Yoon JJ, Toots M, Lee S, Lee ME, Ludeke B, Luczo JM, एवं अन्य (August 2018). "Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses". Antimicrobial Agents and Chemotherapy. 62 (8): e00766–18. PMID 29891600. डीओआइ:10.1128/AAC.00766-18. पी॰एम॰सी॰ 6105843.
Lumby, Casper (3 March 2020). "Favipiravir and Zanamivir Cleared Infection with Influenza B in a Severely Immunocompromised Child". Clinical Infectious Diseases. 71 (7): e191–e194. PMID 32124919. डीओआइ:10.1093/cid/ciaa023.
Hayden FG, Shindo N (April 2019). "Influenza virus polymerase inhibitors in clinical development". Current Opinion in Infectious Diseases. 32 (2): 176–186. PMID 30724789. डीओआइ:10.1097/QCO.0000000000000532. पी॰एम॰सी॰ 6416007.
Ueda, Munetaka; Tanimoto, Tetsuya; Murayama, Anju; Ozaki, Akihiko; Kami, Masahiro (2021). "Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir". Clinical Pharmacology & Therapeutics (अंग्रेज़ी में). n/a (n/a). PMID 33882157 |pmid= के मान की जाँच करें (मदद). आइ॰एस॰एस॰एन॰ 1532-6535. डीओआइ:10.1002/cpt.2251. पी॰एम॰सी॰ 8251038 |pmc= के मान की जाँच करें (मदद).
Vaidyanathan, Gayathri (2020-11-09). "Scientists criticize use of unproven COVID drugs in India". Nature (अंग्रेज़ी में). 587 (7833): 187–188. PMID 33169025 |pmid= के मान की जाँच करें (मदद). डीओआइ:10.1038/d41586-020-03105-7. बिबकोड:2020Natur.587..187V.
Shrestha DB, Budhathoki P, Khadka S, Shah PB, Pokharel N, Rashmi P (September 2020). "Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis". Virol J. 17 (1): 141. PMID 32972430. डीओआइ:10.1186/s12985-020-01412-z. पी॰एम॰सी॰ 7512218 |pmc= के मान की जाँच करें (मदद).
Gatherer D (August 2014). "The 2014 Ebola virus disease outbreak in West Africa". The Journal of General Virology. 95 (Pt 8): 1619–1624. PMID 24795448. डीओआइ:10.1099/vir.0.067199-0.
Oestereich L, Lüdtke A, Wurr S, Rieger T, Muñoz-Fontela C, Günther S (May 2014). "Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model". Antiviral Research. 105: 17–21. PMID 24583123. डीओआइ:10.1016/j.antiviral.2014.02.014.
Smither SJ, Eastaugh LS, Steward JA, Nelson M, Lenk RP, Lever MS (April 2014). "Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model". Antiviral Research. 104: 153–5. PMID 24462697. डीओआइ:10.1016/j.antiviral.2014.01.012.
Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, एवं अन्य (March 2016). "Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea". PLOS Medicine. 13 (3): e1001967. PMID 26930627. डीओआइ:10.1371/journal.pmed.1001967. पी॰एम॰सी॰ 4773183.
Cohen, Jon (26 February 2015). "Results from encouraging Ebola trial scrutinized". Science. डीओआइ:10.1126/science.aaa7912. अभिगमन तिथि 21 January 2016.
Banerjee, Sayantan; Gupta, Nitin; Kodan, Parul; Mittal, Ankit; Ray, Yogiraj; Nischal, Neeraj; Soneja, Manish; Biswas, Ashutosh; Wig, Naveet (February 2019). "Nipah virus disease: A rare and intractable disease". Intractable & Rare Diseases Research. 8 (1): 1–8. PMID 30881850. आइ॰एस॰एस॰एन॰ 2186-3644. डीओआइ:10.5582/irdr.2018.01130. पी॰एम॰सी॰ 6409114.
Dawes, Brian E.; Kalveram, Birte; Ikegami, Tetsuro; Juelich, Terry; Smith, Jennifer K.; Zhang, Lihong; Park, Arnold; Lee, Benhur; Komeno, Takashi (15 May 2018). "Favipiravir (T-705) protects against Nipah virus infection in the hamster model". Scientific Reports. 8 (1): 7604. PMID 29765101. आइ॰एस॰एस॰एन॰ 2045-2322. डीओआइ:10.1038/s41598-018-25780-3. पी॰एम॰सी॰ 5954062. बिबकोड:2018NatSR...8.7604D.
Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, एवं अन्य (June 2009). "T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections". Antiviral Research. 82 (3): 95–102. PMID 19428599. डीओआइ:10.1016/j.antiviral.2009.02.198. पी॰एम॰सी॰ 7127082 |pmc= के मान की जाँच करें (मदद).
Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL (November 2013). "Favipiravir (T-705), a novel viral RNA polymerase inhibitor". Antiviral Research. 100 (2): 446–54. PMID 24084488. डीओआइ:10.1016/j.antiviral.2013.09.015. पी॰एम॰सी॰ 3880838.
Caroline AL, Powell DS, Bethel LM, Oury TD, Reed DS, Hartman AL (April 2014). "Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever". PLOS Neglected Tropical Diseases. 8 (4): e2790. PMID 24722586. डीओआइ:10.1371/journal.pntd.0002790. पी॰एम॰सी॰ 3983105.
Mumtaz N, van Kampen JJ, Reusken CB, Boucher CA, Koopmans MP (2016). "Zika Virus: Where Is the Treatment?". Current Treatment Options in Infectious Diseases. 8 (3): 208–211. PMID 27547128. डीओआइ:10.1007/s40506-016-0083-7. पी॰एम॰सी॰ 4969322.
Yamada K, Noguchi K, Komeno T, Furuta Y, Nishizono A (April 2016). "Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis". The Journal of Infectious Diseases. 213 (8): 1253–61. PMID 26655300. डीओआइ:10.1093/infdis/jiv586. पी॰एम॰सी॰ 4799667.
Murphy J, Sifri CD, Pruitt R, Hornberger M, Bonds D, Blanton J, एवं अन्य (January 2019). "Human Rabies - Virginia, 2017". MMWR. Morbidity and Mortality Weekly Report (अंग्रेज़ी में). 67 (5152): 1410–1414. PMID 30605446. डीओआइ:10.15585/mmwr.mm675152a2. पी॰एम॰सी॰ 6334827.
Antonov L (2020). "Favipiravir tautomerism: a theoretical insight". Theoretical Chemistry Accounts. 139 (8): 145. PMID 32834770. डीओआइ:10.1007/s00214-020-02656-2. पी॰एम॰सी॰ 7415411 |pmc= के मान की जाँच करें (मदद).

fiercepharma.com

EJ Lane (June 22, 2016). "Fujifilm in Avigan API license with Zhejiang Hisun Pharmaceuticals". Fierce Pharma. अभिगमन तिथि April 20, 2020.

harvard.edu

ui.adsabs.harvard.edu

Jin Z, Smith LK, Rajwanshi VK, Kim B, Deval J (2013). "The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase". PLOS ONE. 8 (7): e68347. PMID 23874596. डीओआइ:10.1371/journal.pone.0068347. पी॰एम॰सी॰ 3707847. बिबकोड:2013PLoSO...868347J. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "bp" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
Vaidyanathan, Gayathri (2020-11-09). "Scientists criticize use of unproven COVID drugs in India". Nature (अंग्रेज़ी में). 587 (7833): 187–188. PMID 33169025 |pmid= के मान की जाँच करें (मदद). डीओआइ:10.1038/d41586-020-03105-7. बिबकोड:2020Natur.587..187V.
Dawes, Brian E.; Kalveram, Birte; Ikegami, Tetsuro; Juelich, Terry; Smith, Jennifer K.; Zhang, Lihong; Park, Arnold; Lee, Benhur; Komeno, Takashi (15 May 2018). "Favipiravir (T-705) protects against Nipah virus infection in the hamster model". Scientific Reports. 8 (1): 7604. PMID 29765101. आइ॰एस॰एस॰एन॰ 2045-2322. डीओआइ:10.1038/s41598-018-25780-3. पी॰एम॰सी॰ 5954062. बिबकोड:2018NatSR...8.7604D.

medum.ru

"Avifavir". Russian drug reference. Medum.ru.
"Arelpivir". Russian drug reference. Medum.ru.

nih.gov

pubmed.ncbi.nlm.nih.gov

Du YX, Chen XP (April 2020). "Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection". Clinical Pharmacology and Therapeutics. 108 (2): 242–247. PMID 32246834. डीओआइ:10.1002/cpt.1844.
Furuta, Yousuke; Takahashi, Kazumi; Shiraki, Kimiyasu; Sakamoto, Kenichi; Smee, Donald F.; Barnard, Dale L.; Gowen, Brian B.; Julander, Justin G.; Morrey, John D. (2009). "T-705 (Favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections". Antiviral Research. 82 (3): 95–102. PMID 19428599. डीओआइ:10.1016/j.antiviral.2009.02.198. पी॰एम॰सी॰ 7127082 |pmc= के मान की जाँच करें (मदद).
Shiraki K, Daikoku T (February 2020). "Favipiravir, an anti-influenza drug against life-threatening RNA virus infections". Pharmacology & Therapeutics. 209: 107512. PMID 32097670. डीओआइ:10.1016/j.pharmthera.2020.107512. पी॰एम॰सी॰ 7102570 |pmc= के मान की जाँच करें (मदद). सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "Shi2020" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
Pilkington, Victoria; Pepperrell, Toby; Hill, Andrew (2020). "A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?". Journal of Virus Eradication. 6 (2): 45–51. PMID 32405421. आइ॰एस॰एस॰एन॰ 2055-6640. डीओआइ:10.1016/S2055-6640(20)30016-9. पी॰एम॰सी॰ 7331506 |pmc= के मान की जाँच करें (मदद).
Jin Z, Smith LK, Rajwanshi VK, Kim B, Deval J (2013). "The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase". PLOS ONE. 8 (7): e68347. PMID 23874596. डीओआइ:10.1371/journal.pone.0068347. पी॰एम॰सी॰ 3707847. बिबकोड:2013PLoSO...868347J. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "bp" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
Guedj J, Piorkowski G, Jacquot F, Madelain V, Nguyen TH, Rodallec A, एवं अन्य (March 2018). "Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques". PLOS Medicine. 15 (3): e1002535. PMID 29584730. डीओआइ:10.1371/journal.pmed.1002535. पी॰एम॰सी॰ 5870946.
Smee DF, Hurst BL, Egawa H, Takahashi K, Kadota T, Furuta Y (October 2009). "Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells". The Journal of Antimicrobial Chemotherapy. 64 (4): 741–6. PMID 19643775. डीओआइ:10.1093/jac/dkp274. पी॰एम॰सी॰ 2740635.
Yoon JJ, Toots M, Lee S, Lee ME, Ludeke B, Luczo JM, एवं अन्य (August 2018). "Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses". Antimicrobial Agents and Chemotherapy. 62 (8): e00766–18. PMID 29891600. डीओआइ:10.1128/AAC.00766-18. पी॰एम॰सी॰ 6105843.
Lumby, Casper (3 March 2020). "Favipiravir and Zanamivir Cleared Infection with Influenza B in a Severely Immunocompromised Child". Clinical Infectious Diseases. 71 (7): e191–e194. PMID 32124919. डीओआइ:10.1093/cid/ciaa023.
Hayden FG, Shindo N (April 2019). "Influenza virus polymerase inhibitors in clinical development". Current Opinion in Infectious Diseases. 32 (2): 176–186. PMID 30724789. डीओआइ:10.1097/QCO.0000000000000532. पी॰एम॰सी॰ 6416007.
Ueda, Munetaka; Tanimoto, Tetsuya; Murayama, Anju; Ozaki, Akihiko; Kami, Masahiro (2021). "Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir". Clinical Pharmacology & Therapeutics (अंग्रेज़ी में). n/a (n/a). PMID 33882157 |pmid= के मान की जाँच करें (मदद). आइ॰एस॰एस॰एन॰ 1532-6535. डीओआइ:10.1002/cpt.2251. पी॰एम॰सी॰ 8251038 |pmc= के मान की जाँच करें (मदद).
Vaidyanathan, Gayathri (2020-11-09). "Scientists criticize use of unproven COVID drugs in India". Nature (अंग्रेज़ी में). 587 (7833): 187–188. PMID 33169025 |pmid= के मान की जाँच करें (मदद). डीओआइ:10.1038/d41586-020-03105-7. बिबकोड:2020Natur.587..187V.
Shrestha DB, Budhathoki P, Khadka S, Shah PB, Pokharel N, Rashmi P (September 2020). "Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis". Virol J. 17 (1): 141. PMID 32972430. डीओआइ:10.1186/s12985-020-01412-z. पी॰एम॰सी॰ 7512218 |pmc= के मान की जाँच करें (मदद).
Gatherer D (August 2014). "The 2014 Ebola virus disease outbreak in West Africa". The Journal of General Virology. 95 (Pt 8): 1619–1624. PMID 24795448. डीओआइ:10.1099/vir.0.067199-0.
Oestereich L, Lüdtke A, Wurr S, Rieger T, Muñoz-Fontela C, Günther S (May 2014). "Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model". Antiviral Research. 105: 17–21. PMID 24583123. डीओआइ:10.1016/j.antiviral.2014.02.014.
Smither SJ, Eastaugh LS, Steward JA, Nelson M, Lenk RP, Lever MS (April 2014). "Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model". Antiviral Research. 104: 153–5. PMID 24462697. डीओआइ:10.1016/j.antiviral.2014.01.012.
Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, एवं अन्य (March 2016). "Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea". PLOS Medicine. 13 (3): e1001967. PMID 26930627. डीओआइ:10.1371/journal.pmed.1001967. पी॰एम॰सी॰ 4773183.
Banerjee, Sayantan; Gupta, Nitin; Kodan, Parul; Mittal, Ankit; Ray, Yogiraj; Nischal, Neeraj; Soneja, Manish; Biswas, Ashutosh; Wig, Naveet (February 2019). "Nipah virus disease: A rare and intractable disease". Intractable & Rare Diseases Research. 8 (1): 1–8. PMID 30881850. आइ॰एस॰एस॰एन॰ 2186-3644. डीओआइ:10.5582/irdr.2018.01130. पी॰एम॰सी॰ 6409114.
Dawes, Brian E.; Kalveram, Birte; Ikegami, Tetsuro; Juelich, Terry; Smith, Jennifer K.; Zhang, Lihong; Park, Arnold; Lee, Benhur; Komeno, Takashi (15 May 2018). "Favipiravir (T-705) protects against Nipah virus infection in the hamster model". Scientific Reports. 8 (1): 7604. PMID 29765101. आइ॰एस॰एस॰एन॰ 2045-2322. डीओआइ:10.1038/s41598-018-25780-3. पी॰एम॰सी॰ 5954062. बिबकोड:2018NatSR...8.7604D.
Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, एवं अन्य (June 2009). "T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections". Antiviral Research. 82 (3): 95–102. PMID 19428599. डीओआइ:10.1016/j.antiviral.2009.02.198. पी॰एम॰सी॰ 7127082 |pmc= के मान की जाँच करें (मदद).
Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL (November 2013). "Favipiravir (T-705), a novel viral RNA polymerase inhibitor". Antiviral Research. 100 (2): 446–54. PMID 24084488. डीओआइ:10.1016/j.antiviral.2013.09.015. पी॰एम॰सी॰ 3880838.
Caroline AL, Powell DS, Bethel LM, Oury TD, Reed DS, Hartman AL (April 2014). "Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever". PLOS Neglected Tropical Diseases. 8 (4): e2790. PMID 24722586. डीओआइ:10.1371/journal.pntd.0002790. पी॰एम॰सी॰ 3983105.
Mumtaz N, van Kampen JJ, Reusken CB, Boucher CA, Koopmans MP (2016). "Zika Virus: Where Is the Treatment?". Current Treatment Options in Infectious Diseases. 8 (3): 208–211. PMID 27547128. डीओआइ:10.1007/s40506-016-0083-7. पी॰एम॰सी॰ 4969322.
Yamada K, Noguchi K, Komeno T, Furuta Y, Nishizono A (April 2016). "Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis". The Journal of Infectious Diseases. 213 (8): 1253–61. PMID 26655300. डीओआइ:10.1093/infdis/jiv586. पी॰एम॰सी॰ 4799667.
Murphy J, Sifri CD, Pruitt R, Hornberger M, Bonds D, Blanton J, एवं अन्य (January 2019). "Human Rabies - Virginia, 2017". MMWR. Morbidity and Mortality Weekly Report (अंग्रेज़ी में). 67 (5152): 1410–1414. PMID 30605446. डीओआइ:10.15585/mmwr.mm675152a2. पी॰एम॰सी॰ 6334827.
Antonov L (2020). "Favipiravir tautomerism: a theoretical insight". Theoretical Chemistry Accounts. 139 (8): 145. PMID 32834770. डीओआइ:10.1007/s00214-020-02656-2. पी॰एम॰सी॰ 7415411 |pmc= के मान की जाँच करें (मदद).

ncbi.nlm.nih.gov

Furuta, Yousuke; Takahashi, Kazumi; Shiraki, Kimiyasu; Sakamoto, Kenichi; Smee, Donald F.; Barnard, Dale L.; Gowen, Brian B.; Julander, Justin G.; Morrey, John D. (2009). "T-705 (Favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections". Antiviral Research. 82 (3): 95–102. PMID 19428599. डीओआइ:10.1016/j.antiviral.2009.02.198. पी॰एम॰सी॰ 7127082 |pmc= के मान की जाँच करें (मदद).
Shiraki K, Daikoku T (February 2020). "Favipiravir, an anti-influenza drug against life-threatening RNA virus infections". Pharmacology & Therapeutics. 209: 107512. PMID 32097670. डीओआइ:10.1016/j.pharmthera.2020.107512. पी॰एम॰सी॰ 7102570 |pmc= के मान की जाँच करें (मदद). सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "Shi2020" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
Pilkington, Victoria; Pepperrell, Toby; Hill, Andrew (2020). "A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?". Journal of Virus Eradication. 6 (2): 45–51. PMID 32405421. आइ॰एस॰एस॰एन॰ 2055-6640. डीओआइ:10.1016/S2055-6640(20)30016-9. पी॰एम॰सी॰ 7331506 |pmc= के मान की जाँच करें (मदद).
Jin Z, Smith LK, Rajwanshi VK, Kim B, Deval J (2013). "The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase". PLOS ONE. 8 (7): e68347. PMID 23874596. डीओआइ:10.1371/journal.pone.0068347. पी॰एम॰सी॰ 3707847. बिबकोड:2013PLoSO...868347J. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "bp" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
Guedj J, Piorkowski G, Jacquot F, Madelain V, Nguyen TH, Rodallec A, एवं अन्य (March 2018). "Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques". PLOS Medicine. 15 (3): e1002535. PMID 29584730. डीओआइ:10.1371/journal.pmed.1002535. पी॰एम॰सी॰ 5870946.
Smee DF, Hurst BL, Egawa H, Takahashi K, Kadota T, Furuta Y (October 2009). "Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells". The Journal of Antimicrobial Chemotherapy. 64 (4): 741–6. PMID 19643775. डीओआइ:10.1093/jac/dkp274. पी॰एम॰सी॰ 2740635.
Yoon JJ, Toots M, Lee S, Lee ME, Ludeke B, Luczo JM, एवं अन्य (August 2018). "Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses". Antimicrobial Agents and Chemotherapy. 62 (8): e00766–18. PMID 29891600. डीओआइ:10.1128/AAC.00766-18. पी॰एम॰सी॰ 6105843.
Hayden FG, Shindo N (April 2019). "Influenza virus polymerase inhibitors in clinical development". Current Opinion in Infectious Diseases. 32 (2): 176–186. PMID 30724789. डीओआइ:10.1097/QCO.0000000000000532. पी॰एम॰सी॰ 6416007.
Ueda, Munetaka; Tanimoto, Tetsuya; Murayama, Anju; Ozaki, Akihiko; Kami, Masahiro (2021). "Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir". Clinical Pharmacology & Therapeutics (अंग्रेज़ी में). n/a (n/a). PMID 33882157 |pmid= के मान की जाँच करें (मदद). आइ॰एस॰एस॰एन॰ 1532-6535. डीओआइ:10.1002/cpt.2251. पी॰एम॰सी॰ 8251038 |pmc= के मान की जाँच करें (मदद).
Shrestha DB, Budhathoki P, Khadka S, Shah PB, Pokharel N, Rashmi P (September 2020). "Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis". Virol J. 17 (1): 141. PMID 32972430. डीओआइ:10.1186/s12985-020-01412-z. पी॰एम॰सी॰ 7512218 |pmc= के मान की जाँच करें (मदद).
Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, एवं अन्य (March 2016). "Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea". PLOS Medicine. 13 (3): e1001967. PMID 26930627. डीओआइ:10.1371/journal.pmed.1001967. पी॰एम॰सी॰ 4773183.
Banerjee, Sayantan; Gupta, Nitin; Kodan, Parul; Mittal, Ankit; Ray, Yogiraj; Nischal, Neeraj; Soneja, Manish; Biswas, Ashutosh; Wig, Naveet (February 2019). "Nipah virus disease: A rare and intractable disease". Intractable & Rare Diseases Research. 8 (1): 1–8. PMID 30881850. आइ॰एस॰एस॰एन॰ 2186-3644. डीओआइ:10.5582/irdr.2018.01130. पी॰एम॰सी॰ 6409114.
Dawes, Brian E.; Kalveram, Birte; Ikegami, Tetsuro; Juelich, Terry; Smith, Jennifer K.; Zhang, Lihong; Park, Arnold; Lee, Benhur; Komeno, Takashi (15 May 2018). "Favipiravir (T-705) protects against Nipah virus infection in the hamster model". Scientific Reports. 8 (1): 7604. PMID 29765101. आइ॰एस॰एस॰एन॰ 2045-2322. डीओआइ:10.1038/s41598-018-25780-3. पी॰एम॰सी॰ 5954062. बिबकोड:2018NatSR...8.7604D.
Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, एवं अन्य (June 2009). "T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections". Antiviral Research. 82 (3): 95–102. PMID 19428599. डीओआइ:10.1016/j.antiviral.2009.02.198. पी॰एम॰सी॰ 7127082 |pmc= के मान की जाँच करें (मदद).
Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL (November 2013). "Favipiravir (T-705), a novel viral RNA polymerase inhibitor". Antiviral Research. 100 (2): 446–54. PMID 24084488. डीओआइ:10.1016/j.antiviral.2013.09.015. पी॰एम॰सी॰ 3880838.
Caroline AL, Powell DS, Bethel LM, Oury TD, Reed DS, Hartman AL (April 2014). "Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever". PLOS Neglected Tropical Diseases. 8 (4): e2790. PMID 24722586. डीओआइ:10.1371/journal.pntd.0002790. पी॰एम॰सी॰ 3983105.
Mumtaz N, van Kampen JJ, Reusken CB, Boucher CA, Koopmans MP (2016). "Zika Virus: Where Is the Treatment?". Current Treatment Options in Infectious Diseases. 8 (3): 208–211. PMID 27547128. डीओआइ:10.1007/s40506-016-0083-7. पी॰एम॰सी॰ 4969322.
Yamada K, Noguchi K, Komeno T, Furuta Y, Nishizono A (April 2016). "Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis". The Journal of Infectious Diseases. 213 (8): 1253–61. PMID 26655300. डीओआइ:10.1093/infdis/jiv586. पी॰एम॰सी॰ 4799667.
Murphy J, Sifri CD, Pruitt R, Hornberger M, Bonds D, Blanton J, एवं अन्य (January 2019). "Human Rabies - Virginia, 2017". MMWR. Morbidity and Mortality Weekly Report (अंग्रेज़ी में). 67 (5152): 1410–1414. PMID 30605446. डीओआइ:10.15585/mmwr.mm675152a2. पी॰एम॰सी॰ 6334827.
Antonov L (2020). "Favipiravir tautomerism: a theoretical insight". Theoretical Chemistry Accounts. 139 (8): 145. PMID 32834770. डीओआइ:10.1007/s00214-020-02656-2. पी॰एम॰सी॰ 7415411 |pmc= के मान की जाँच करें (मदद).

nytimes.com

Fink, Sheri (4 February 2015). "Ebola Drug Aids Some in a Study in West Africa". The New York Times.

principletrial.org

"Favipiravir to be investigated as a possible COVID-19 treatment for at-home recovery in the PRINCIPLE trial". PRINCIPLE Trial. 8 April 2021. Led by University of Oxford researchers, PRINCIPLE is one of the UK Government's national priority platform trials for COVID-19 treatments and was set-up with the intention that drugs shown to have a clinical benefit could be rapidly introduced into routine NHS care.

reuters.com

Reuters Staff (2020-09-18). "Russia approves first COVID-19 prescription drug for sale in pharmacies". Reuters (अंग्रेज़ी में). अभिगमन तिथि 2021-05-20.
"First French Ebola patient leaves hospital". Reuters. 4 October 2016.

sciencemag.org

Cohen, Jon (26 February 2015). "Results from encouraging Ebola trial scrutinized". Science. डीओआइ:10.1126/science.aaa7912. अभिगमन तिथि 21 January 2016.

telex.hu

"A kórházakat tehermentesítheti az egyforintos koronavírus-gyógyszer". telex (हंगेरियाई में). 2021-03-11. अभिगमन तिथि 2021-03-30.

thewire.in

science.thewire.in

Pulla, Priyanka (2020-11-25). "Is Favipiravir Good for COVID-19? Clinical Trial Says No, Press Release Says Yes". The Wire Science (अंग्रेज़ी में). अभिगमन तिथि 2021-05-20.

worldcat.org

Pilkington, Victoria; Pepperrell, Toby; Hill, Andrew (2020). "A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?". Journal of Virus Eradication. 6 (2): 45–51. PMID 32405421. आइ॰एस॰एस॰एन॰ 2055-6640. डीओआइ:10.1016/S2055-6640(20)30016-9. पी॰एम॰सी॰ 7331506 |pmc= के मान की जाँच करें (मदद).
Ueda, Munetaka; Tanimoto, Tetsuya; Murayama, Anju; Ozaki, Akihiko; Kami, Masahiro (2021). "Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir". Clinical Pharmacology & Therapeutics (अंग्रेज़ी में). n/a (n/a). PMID 33882157 |pmid= के मान की जाँच करें (मदद). आइ॰एस॰एस॰एन॰ 1532-6535. डीओआइ:10.1002/cpt.2251. पी॰एम॰सी॰ 8251038 |pmc= के मान की जाँच करें (मदद).
Banerjee, Sayantan; Gupta, Nitin; Kodan, Parul; Mittal, Ankit; Ray, Yogiraj; Nischal, Neeraj; Soneja, Manish; Biswas, Ashutosh; Wig, Naveet (February 2019). "Nipah virus disease: A rare and intractable disease". Intractable & Rare Diseases Research. 8 (1): 1–8. PMID 30881850. आइ॰एस॰एस॰एन॰ 2186-3644. डीओआइ:10.5582/irdr.2018.01130. पी॰एम॰सी॰ 6409114.
Dawes, Brian E.; Kalveram, Birte; Ikegami, Tetsuro; Juelich, Terry; Smith, Jennifer K.; Zhang, Lihong; Park, Arnold; Lee, Benhur; Komeno, Takashi (15 May 2018). "Favipiravir (T-705) protects against Nipah virus infection in the hamster model". Scientific Reports. 8 (1): 7604. PMID 29765101. आइ॰एस॰एस॰एन॰ 2045-2322. डीओआइ:10.1038/s41598-018-25780-3. पी॰एम॰सी॰ 5954062. बिबकोड:2018NatSR...8.7604D.